| Dr Dean Ting-yuan Chiang, MD | |
|
3440 Lomita Blvd, Suite 228, Torrance, CA 90505-4801 | |
| (310) 326-3371 | |
| (310) 326-2294 |
| Full Name | Dr Dean Ting-yuan Chiang |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 25 Years |
| Location | 3440 Lomita Blvd, Torrance, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760484455 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | A73856 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Torrance Memorial Medical Center | Torrance, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allan D Singer Md Inc And Dean T Chiang Md Inc A Medical Partnership | 8527147610 | 2 |
| Sutter Bay Medical Foundation | 4284538778 | 2941 |
News Archive
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports.
A new medical device which combines nanotechnology with a pregnancy tester could help diagnose and treat the 1 million people in the UK who don't know they have kidney disease, a new report by the Institution of Mechanical Engineers reveals today.
To help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered a new stem cell line to study the conversion of stem cells into muscle. Findings appeared in Cell Reports.
Repligen Corporation today announced preliminary financial results for fiscal year 2010 which ended March 31, 2010. Total revenue for the year is expected to be $21.0 million, including $10.3 million of bioprocessing product revenue and $10.7 million of royalty and other revenue. Research and development expenses are expected to be between $13.8-$14.2 million and selling, general and administrative expenses between $6.8-$7.2 million.
Year-old changes to the system that distributes deceased donor kidneys nationwide have significantly boosted transplantation rates for black and Hispanic patients on waiting lists, reducing racial disparities inherent in the previous allocation formula used for decades, according to results of research led by a Johns Hopkins transplant surgeon.
› Verified 8 days ago
| Entity Name | Providence Medical Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417915760 PECOS PAC ID: 5991609737 Enrollment ID: O20031121000910 |
News Archive
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports.
A new medical device which combines nanotechnology with a pregnancy tester could help diagnose and treat the 1 million people in the UK who don't know they have kidney disease, a new report by the Institution of Mechanical Engineers reveals today.
To help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered a new stem cell line to study the conversion of stem cells into muscle. Findings appeared in Cell Reports.
Repligen Corporation today announced preliminary financial results for fiscal year 2010 which ended March 31, 2010. Total revenue for the year is expected to be $21.0 million, including $10.3 million of bioprocessing product revenue and $10.7 million of royalty and other revenue. Research and development expenses are expected to be between $13.8-$14.2 million and selling, general and administrative expenses between $6.8-$7.2 million.
Year-old changes to the system that distributes deceased donor kidneys nationwide have significantly boosted transplantation rates for black and Hispanic patients on waiting lists, reducing racial disparities inherent in the previous allocation formula used for decades, according to results of research led by a Johns Hopkins transplant surgeon.
› Verified 8 days ago
| Entity Name | Sutter Bay Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports.
A new medical device which combines nanotechnology with a pregnancy tester could help diagnose and treat the 1 million people in the UK who don't know they have kidney disease, a new report by the Institution of Mechanical Engineers reveals today.
To help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered a new stem cell line to study the conversion of stem cells into muscle. Findings appeared in Cell Reports.
Repligen Corporation today announced preliminary financial results for fiscal year 2010 which ended March 31, 2010. Total revenue for the year is expected to be $21.0 million, including $10.3 million of bioprocessing product revenue and $10.7 million of royalty and other revenue. Research and development expenses are expected to be between $13.8-$14.2 million and selling, general and administrative expenses between $6.8-$7.2 million.
Year-old changes to the system that distributes deceased donor kidneys nationwide have significantly boosted transplantation rates for black and Hispanic patients on waiting lists, reducing racial disparities inherent in the previous allocation formula used for decades, according to results of research led by a Johns Hopkins transplant surgeon.
› Verified 8 days ago
| Entity Name | Allan D Singer Md Inc And Dean T Chiang Md Inc A Medical Partnership |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295916021 PECOS PAC ID: 8527147610 Enrollment ID: O20080430000516 |
News Archive
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports.
A new medical device which combines nanotechnology with a pregnancy tester could help diagnose and treat the 1 million people in the UK who don't know they have kidney disease, a new report by the Institution of Mechanical Engineers reveals today.
To help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered a new stem cell line to study the conversion of stem cells into muscle. Findings appeared in Cell Reports.
Repligen Corporation today announced preliminary financial results for fiscal year 2010 which ended March 31, 2010. Total revenue for the year is expected to be $21.0 million, including $10.3 million of bioprocessing product revenue and $10.7 million of royalty and other revenue. Research and development expenses are expected to be between $13.8-$14.2 million and selling, general and administrative expenses between $6.8-$7.2 million.
Year-old changes to the system that distributes deceased donor kidneys nationwide have significantly boosted transplantation rates for black and Hispanic patients on waiting lists, reducing racial disparities inherent in the previous allocation formula used for decades, according to results of research led by a Johns Hopkins transplant surgeon.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dean Ting-yuan Chiang, MD 3440 Lomita Blvd, Suite 228, Torrance, CA 90505-4801 Ph: (310) 326-3371 | Dr Dean Ting-yuan Chiang, MD 3440 Lomita Blvd, Suite 228, Torrance, CA 90505-4801 Ph: (310) 326-3371 |
News Archive
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) "are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday" during the launch of "a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively," Reuters reports.
A new medical device which combines nanotechnology with a pregnancy tester could help diagnose and treat the 1 million people in the UK who don't know they have kidney disease, a new report by the Institution of Mechanical Engineers reveals today.
To help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered a new stem cell line to study the conversion of stem cells into muscle. Findings appeared in Cell Reports.
Repligen Corporation today announced preliminary financial results for fiscal year 2010 which ended March 31, 2010. Total revenue for the year is expected to be $21.0 million, including $10.3 million of bioprocessing product revenue and $10.7 million of royalty and other revenue. Research and development expenses are expected to be between $13.8-$14.2 million and selling, general and administrative expenses between $6.8-$7.2 million.
Year-old changes to the system that distributes deceased donor kidneys nationwide have significantly boosted transplantation rates for black and Hispanic patients on waiting lists, reducing racial disparities inherent in the previous allocation formula used for decades, according to results of research led by a Johns Hopkins transplant surgeon.
› Verified 8 days ago
Dr. Heather Suzanne Volpp, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 20911 Earl St Ste 301, Torrance, CA 90503 Phone: 310-371-1388 Fax: 310-371-3439 | |
Ellyn Ashida, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4201 Torrance Blvd, 730, Torrance, CA 90503 Phone: 310-944-9098 | |
Dr. Edward George Buchsbaum, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 20911 Earl Street, Suite 301, Torrance, CA 90503 Phone: 310-371-1388 Fax: 310-371-3439 | |
Dr. Allan David Singer, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3440 Lomita Blvd, Ste 228, Torrance, CA 90505 Phone: 310-326-3371 Fax: 310-326-2294 | |
Julia Shin Lee, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 20911 Earl St Ste 301, Torrance, CA 90503 Phone: 310-371-1388 Fax: 310-371-3439 | |
Joyce Jeong-mi Schoettler, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 20911 Earl St Ste 301, Torrance, CA 90503 Phone: 310-371-1388 Fax: 310-371-3439 |